Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1978 Feb;31(2):328–338.

Hereditary C2 deficiency and systemic lupus erythematosus associated with severe glomerulonephritis.

J L Roberts, M M Schwartz, E J Lewis
PMCID: PMC1541209  PMID: 348363

Abstract

Although an unusually high incidence of immunological diseases has been described in patients with hereditary C2 deficiency, the severity of these illnesses has been relatively mild, suggesting that blocking complement activation beyond C4 may protect against significant complement-mediated inflammation. This report describes studies in a C2-deficient patient with severe systemic lupus erythematosus (SLE) and diffuse proliferative glomerulonephritis. An immunopathological study of the kidney revealed the deposition of properdin, properdin factor B, C3 and C5 in a pattern similar to immunoglobulin G deposits. Serum properdin and properdin factor B levels were low at various times during the patient's course. In vitro complement fixation studies showed C3 fixation by glomerular deposits could occur via the alternative pathway. Studies of the immune deposits in the patients' skin revealed similar results. These studies suggest that inflammation may be effectively mediated via the alternative complement pathway in the C2 deficiency-lupus syndrome.

Full text

PDF
328

Images in this article

331FIG. 1
on p.331
332FIG. 2
on p.332
333FIG. 3
on p.333
333FIG. 4
on p.333

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarden L. A., de Groot E. R., Feltkamp T. E. Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann N Y Acad Sci. 1975 Jun 30;254:505–515. doi: 10.1111/j.1749-6632.1975.tb29197.x. [DOI] [PubMed] [Google Scholar]
  2. Agnello V., De Bracco M. M., Kunkel H. G. Hereditary C2 deficiency with some manifestations of systemic lupus erythematosus. J Immunol. 1972 Mar;108(3):837–840. [PubMed] [Google Scholar]
  3. Cooper N. R., ten Bensel R., Kohler P. F. Studies of an additional kindred with hereditary deficiency of the second component of human complement (C2) and description of a new method for the quantitation of C2. J Immunol. 1968 Dec;101(6):1176–1182. [PubMed] [Google Scholar]
  4. Couser W. G., Stilmant M., Lewis E. J. Experimental glomerulonephritis in the guinea pig. I. Glomerular lesions associated with antiglomerular basement membrane antibody deposits. Lab Invest. 1973 Aug;29(2):236–243. [PubMed] [Google Scholar]
  5. Day N. K., Geiger H., McLean R., Michael A., Good R. A. C2 deficiency. Development of lupus erythematosus. J Clin Invest. 1973 Jul;52(7):1601–1607. doi: 10.1172/JCI107337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Douglass M. C., Lamberg S. I., Lorincz A. L., Good R. A., Day N. K. Lupus erythematosus-like syndrome with a familial deficiency of C2. Arch Dermatol. 1976 May;112(5):671–674. [PubMed] [Google Scholar]
  7. Einstein L. P., Alper C. A., Bloch K. J., Herrin J. T., Rosen F. S., David J. R., Colten H. R. Biosynthetic defect in monocytes from human beings with genetic deficiency of the second component of complement. N Engl J Med. 1975 May 29;292(22):1169–1171. doi: 10.1056/NEJM197505292922207. [DOI] [PubMed] [Google Scholar]
  8. Fearon D. T., Austen K. F. Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase. J Exp Med. 1975 Oct 1;142(4):856–863. doi: 10.1084/jem.142.4.856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fine D. P., Marney S. R., Jr, Colley D. G., Sergent J. S., Des Prez R. M. C3 shunt activation in human serum chelated with EGTA. J Immunol. 1972 Oct;109(4):807–809. [PubMed] [Google Scholar]
  10. Friend P., Repine J. E., Clawson C. C., Michael A. F. Deficiency of the second component of complement (C2) with chronic vasculitis. Ann Intern Med. 1975 Dec;83(6):813–816. doi: 10.7326/0003-4819-83-6-813. [DOI] [PubMed] [Google Scholar]
  11. Gelfand E. W., Clarkson J. E., Minta J. O. Selective deficiency of the second component of complement in a patient with anaphylactoid purpura. Clin Immunol Immunopathol. 1975 Jul;4(2):269–276. doi: 10.1016/0090-1229(75)90062-8. [DOI] [PubMed] [Google Scholar]
  12. Jordon R. E., Nordby J. M., Milstein H. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody. J Lab Clin Med. 1975 Nov;86(5):733–740. [PubMed] [Google Scholar]
  13. Jordon R. E., Sams W. M., Jr, Beutner E. H. Complement immunofluorescent staining in bullous pemphigoid. J Lab Clin Med. 1969 Oct;74(4):548–556. [PubMed] [Google Scholar]
  14. Klemperer M. R., Austen K. F., Rosen F. S. Hereditary deficiency of the second component of complement (C'2) in man: further observations on a second kindred. J Immunol. 1967 Jan;98(1):72–78. [PubMed] [Google Scholar]
  15. Klemperer M. R., Woodworth H. C., Rosen F. S., Austen K. F. Hereditary deficiency of the second component of complement (C'2) in man. J Clin Invest. 1966 Jun;45(6):880–890. doi: 10.1172/JCI105403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Koffler D., Paronetto F. Immunofluorescent localization of immunoglobulins, complement, and fibrinogen in human diseases. II. Acute, subacute, and chronic glomerulonephritis. J Clin Invest. 1965 Oct;44(10):1665–1671. doi: 10.1172/JCI105273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Leddy J. P., Griggs R. C., Klemperer M. R., Frank M. M. Hereditary complement (C2) deficiency with dermatomyositis. Am J Med. 1975 Jan;58(1):83–91. doi: 10.1016/0002-9343(75)90537-9. [DOI] [PubMed] [Google Scholar]
  18. Lewis E. J., Busch G. J., Schur P. H. Gamma G globulin subgroup composition of the glomerular deposits in human renal diseases. J Clin Invest. 1970 Jun;49(6):1103–1113. doi: 10.1172/JCI106326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lewis E. J., Cavallo T., Harrington J. T., Cotran R. S. An immunopathologic study of rapidly progressive glomerulonephritis in the adult. Hum Pathol. 1971 Jun;2(2):185–208. doi: 10.1016/s0046-8177(71)80034-5. [DOI] [PubMed] [Google Scholar]
  20. McCluskey R. T., Vassalli P., Gallo G., Baldwin D. S. An immunofluorescent study of pathogenic mechanisms in glomerular diseases. N Engl J Med. 1966 Mar 31;274(13):695–701. doi: 10.1056/NEJM196603312741301. [DOI] [PubMed] [Google Scholar]
  21. Michael A. F., McLean R. H. Evidence for activation of the alternate pathway in glomerulonephritis. Adv Nephrol Necker Hosp. 1974;4:49–66. [PubMed] [Google Scholar]
  22. Osterland C. K., Espinoza L., Parker L. P., Schur P. H. Inherited C2 deficiency and systemic lupus erythematosus: studies on a family. Ann Intern Med. 1975 Mar;82(3):323–328. doi: 10.7326/0003-4819-82-3-323. [DOI] [PubMed] [Google Scholar]
  23. Paronetto F., Koffler D. Immunofluorescent localization of immunoglobulins, complement, and fibrinogen in human diseases. I. Systemic lupus erythematosus. J Clin Invest. 1965 Oct;44(10):1657–1664. doi: 10.1172/JCI105272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pickering R. J., Michael A. F., Jr, Herdman R. C., Good R. A., Gewurz H. The complement system in chronic glomerulonephritis: three newly associated aberrations. J Pediatr. 1971 Jan;78(1):30–43. doi: 10.1016/s0022-3476(71)80261-5. [DOI] [PubMed] [Google Scholar]
  25. Repine J. E., Clawson C. C., Friend P. S. Influence of a deficiency of the second component of complement on the bactericidal activity of neutrophils in vitro. J Clin Invest. 1977 May;59(5):802–809. doi: 10.1172/JCI108702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ruddy S., Klemperer M. R., Rosen F. S., Austen K. F., Kumate J. Hereditary deficiency of the second component of complement (C2) in man: correlation of C2 haemolytic activity with immunochemical measurements of C2 protein. Immunology. 1970 Jun;18(6):943–954. [PMC free article] [PubMed] [Google Scholar]
  27. Schwartz M. M., Lewis E. J. Immunopathology of the nephrotic syndrome associated with renal vein thrombosis. Report of two cases and brief review of the literature. Am J Med. 1973 Apr;54(4):528–534. doi: 10.1016/0002-9343(73)90049-1. [DOI] [PubMed] [Google Scholar]
  28. Stern R., Fu S. M., Fotino M., Agnello V., Kunkel H. G. Hereditary C2 deficiency: association with skin lesions resembling the discoid lesion of systemic lupus erythematosus. Arthritis Rheum. 1976 May-Jun;19(3):517–522. doi: 10.1002/art.1780190302. [DOI] [PubMed] [Google Scholar]
  29. Sussman M., Jones J. H., Almeida J. D., Lachmann P. J. Deficiency of the second component of complement associated with anaphylactoid purpura and presence of mycoplasma in the serum. Clin Exp Immunol. 1973 Aug;14(4):531–539. [PMC free article] [PubMed] [Google Scholar]
  30. Thomson N. M., Naish P. F., Simpson I. J., Peters D. K. The role of C3 in the autologous phase of nephrotoxic nephritis. Clin Exp Immunol. 1976 Jun;24(3):464–473. [PMC free article] [PubMed] [Google Scholar]
  31. Thomson N. M., Simpson I. J., Peters D. K. A quantitative evaluation of anticoagulants in experimental nephrotoxic nephritis. Clin Exp Immunol. 1975 Feb;19(2):301–308. [PMC free article] [PubMed] [Google Scholar]
  32. Wild J. H., Zvaifler N. J., Müller-Eberhard H. J., Wilson C. B. C3 metabolism in a patient with deficiency of the second component of complement (C2) and discoid lupus erythematosus. Clin Exp Immunol. 1976 May;24(2):238–248. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES